Compounded oral semaglutide: check the claims

“Oral semaglutide” is not one product

A swallowed branded tablet, a compounded capsule, drops under the tongue and a dissolving lozenge can all be advertised as oral semaglutide. That does not make them clinically interchangeable. The useful first question is the exact product and route, not simply whether it avoids a needle.

Wegovy now has an FDA-approved oral tablet as well as injectable presentations. Its label describes a specific formulation with an absorption enhancer, SNAC; absorption of the tablet occurs predominantly in the stomach.¹ That approval does not extend to a pharmacy's sublingual drops or lozenges. Our Wegovy pill versus injection guide compares the approved options rather than treating every oral offer as the same medicine.

An ingredient claim is not an absorption study

Semaglutide must reach the bloodstream in a useful amount. A website saying a product is “absorbed under the tongue” is making a claim about that particular formulation. Ask for a human study of the finished product, not a study of injected semaglutide, a patent, or a description of an ingredient used to help absorption.

The right follow-up is practical: what was tested, in whom, for how long, and against what comparator? Blood concentrations, weight change and tolerability answer different questions. A small absorption experiment would not automatically establish long-term weight or cardiovascular outcomes. A screenshot of a laboratory certificate does not answer any of those clinical questions.

The FDA does not review compounded medicines for safety, effectiveness or quality before marketing.² Read our compounding explainer for the distinction between an approved drug and a prescription prepared for an individual need.

Do not compare milligrams across routes yourself

A larger milligram number on a tablet does not necessarily mean a stronger effect than a smaller number on an injection. The approved Wegovy label has product-specific instructions and switching provisions.¹ Those provisions do not establish a conversion to an unapproved compounded drop.

Ask your prescriber to identify the current medicine and proposed replacement in writing, including who will manage a gap in treatment or digestive symptoms. If you have missed treatment, the restart guide explains why the original product and length of interruption matter. Do not overlap products or create a conversion from an online chart.

Read the offer as carefully as the delivery claim

A daily price can obscure the supply period and initial payment. Request the exact formulation, pharmacy name, amount supplied, refill interval and total charge. Ask whether visits, shipping and required tests are included. Our cost guide gives a framework for comparing those terms without assuming the cheapest number is a complete quote.

If a provider cites Wegovy's results, ask it to explain clearly whether it is selling Wegovy or a different formulation. A clear answer is more useful than “same active ingredient” or a promise that the pharmacy is “FDA registered.” Registration does not establish approval of the finished compounded product. Keep a copy of the written offer and clinical explanation before making a decision.